ASX - By Stock
|
TLX |
Re:
Ann: ZIRCON Ph III Imaging Study - Positive Top-Line Results
|
|
ejjwj
|
44 |
15K |
9 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
44
|
15K
|
9
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
ejjwj
|
62 |
17K |
4 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
62
|
17K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
4 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
142
|
38K
|
4
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Suspension from Official Quotation
|
|
ejjwj
|
75 |
21K |
0 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
75
|
21K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Suspension from Official Quotation
|
|
ejjwj
|
75 |
21K |
1 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
75
|
21K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Suspension from Official Quotation
|
|
ejjwj
|
75 |
21K |
1 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
75
|
21K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Jarden price target $6.80
|
|
ejjwj
|
10 |
4.3K |
6 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
10
|
4.3K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to Present at Virtual ASX Small and Mid-Cap Conference
|
|
ejjwj
|
16 |
3.8K |
1 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
16
|
3.8K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to Present at Virtual ASX Small and Mid-Cap Conference
|
|
ejjwj
|
16 |
3.8K |
0 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
16
|
3.8K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex receives IND approval
|
|
ejjwj
|
47 |
13K |
4 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
47
|
13K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex receives IND approval
|
|
ejjwj
|
47 |
13K |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
47
|
13K
|
3
|
|
ASX - By Stock
|
5GN |
Re:
Ann: Webcentral FY22 Results Presentation
|
|
ejjwj
|
32 |
10K |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
32
|
10K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: IND Approval by US FDA for Phase II SAR-Bombesin trial
|
|
ejjwj
|
20 |
11K |
7 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
20
|
11K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: IND Approval by US FDA for Phase II SAR-Bombesin trial
|
|
ejjwj
|
20 |
11K |
1 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
20
|
11K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex receives IND approval
|
|
ejjwj
|
47 |
13K |
4 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
47
|
13K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex receives IND approval
|
|
ejjwj
|
47 |
13K |
4 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
47
|
13K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
ejjwj
|
39 |
7.5K |
1 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
39
|
7.5K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
ejjwj
|
39 |
7.5K |
1 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
39
|
7.5K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
ejjwj
|
39 |
7.5K |
1 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
39
|
7.5K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Trading Halt
|
|
ejjwj
|
39 |
7.5K |
8 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
39
|
7.5K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
MST Financial IXC Presentation - July 14th 2022
|
|
ejjwj
|
33 |
7.2K |
7 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
33
|
7.2K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
MST Financial IXC Presentation - July 14th 2022
|
|
ejjwj
|
33 |
7.2K |
2 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
33
|
7.2K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Paul Hopper IP opportunists CHM VS RAD
|
|
ejjwj
|
28 |
11K |
6 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
28
|
11K
|
6
|
|
ASX - By Stock
|
RAD |
Re:
Paul Hopper IP opportunists CHM VS RAD
|
|
ejjwj
|
28 |
11K |
4 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
28
|
11K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Telix in China
|
|
ejjwj
|
64 |
25K |
2 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
64
|
25K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Telix in China
|
|
ejjwj
|
64 |
25K |
4 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
64
|
25K
|
4
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Investor webinar - RAD adds brain tumor technology
|
|
ejjwj
|
51 |
18K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
51
|
18K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
MST Financial IXC Presentation - July 14th 2022
|
|
ejjwj
|
33 |
7.2K |
5 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
33
|
7.2K
|
5
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
2 |
1.1K |
1 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
ejjwj
|
119 |
32K |
1 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
119
|
32K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Investor webinar - RAD adds brain tumor technology
|
|
ejjwj
|
51 |
18K |
0 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
51
|
18K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
ejjwj
|
119 |
32K |
1 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
119
|
32K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
ejjwj
|
119 |
32K |
4 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
4
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Investor webinar - RAD adds brain tumor technology
|
|
ejjwj
|
51 |
18K |
4 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
51
|
18K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
ejjwj
|
119 |
32K |
8 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
8
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Investor webinar - RAD adds brain tumor technology
|
|
ejjwj
|
51 |
18K |
1 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
51
|
18K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
15 |
3.6K |
1 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
15
|
3.6K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
110 |
17K |
3 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
110
|
17K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
6 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
234
|
85K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
110 |
17K |
3 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
110
|
17K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Take Over offer
|
|
ejjwj
|
24 |
11K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
24
|
11K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
110 |
17K |
1 |
19/06/22 |
19/06/22 |
ASX - By Stock
|
110
|
17K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
110 |
17K |
1 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
110
|
17K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
110 |
17K |
3 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
110
|
17K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
110 |
17K |
6 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
110
|
17K
|
6
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Ltd - Radiopharm And Isotopia Announce Supply Agreement For...
|
|
ejjwj
|
2 |
888 |
5 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
2
|
888
|
5
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD adds Brain Tumor Technology to Portfolio
|
|
ejjwj
|
10 |
3.8K |
3 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
10
|
3.8K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: IND Approval by US FDA for Phase II SAR-Bombesin trial
|
|
ejjwj
|
20 |
11K |
2 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
20
|
11K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Says Doug Cubbin Will Step Down As Group CFO
|
|
ejjwj
|
7 |
2.5K |
6 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
7
|
2.5K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
4 |
29/05/22 |
29/05/22 |
ASX - By Stock
|
287
|
58K
|
4
|
|